147 related articles for article (PubMed ID: 36900332)
21. Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR).
Forschner A; Eichner F; Amaral T; Keim U; Garbe C; Eigentler TK
J Cancer Res Clin Oncol; 2017 Mar; 143(3):533-540. PubMed ID: 27878363
[TBL] [Abstract][Full Text] [Related]
22. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study.
Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O
J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957
[TBL] [Abstract][Full Text] [Related]
23. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
24. Predictors of survival in head and neck mucosal melanoma.
Schmidt MQ; David J; Yoshida EJ; Scher K; Mita A; Shiao SL; Ho AS; Zumsteg ZS
Oral Oncol; 2017 Oct; 73():36-42. PubMed ID: 28939074
[TBL] [Abstract][Full Text] [Related]
25. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology and Survival Outcomes for Eyelid Primary Malignant Melanoma: An Analysis of 1397 Cases in the SEER Database.
Shan Y; Xu Y; Lu Y; Chen M; Cao J; Wang Y; Lin X; Ye J
J Ophthalmol; 2020; 2020():4858636. PubMed ID: 33520295
[TBL] [Abstract][Full Text] [Related]
27. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989-2008.
Hollestein LM; de Vries E; Nijsten T
Eur J Cancer; 2012 Sep; 48(13):2046-53. PubMed ID: 22342554
[TBL] [Abstract][Full Text] [Related]
28. Is melanoma survival influenced by month of diagnosis?
Savoye I; Jegou D; Kvaskoff M; Rommens K; Boutron-Ruault MC; Coppieters Y; Francart J
Cancer Epidemiol; 2015 Oct; 39(5):727-33. PubMed ID: 26220880
[TBL] [Abstract][Full Text] [Related]
29. Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).
Ferguson SD; Bindal S; Bassett RL; Haydu LE; McCutcheon IE; Heimberger AB; Li J; O'Brien BJ; Guha-Thakurta N; Tetzlaff MT; Tawbi H; Davies MA; Glitza IC
J Neurooncol; 2019 May; 142(3):499-509. PubMed ID: 30847840
[TBL] [Abstract][Full Text] [Related]
30. A population-based study on incidence, treatment, and survival in ampullary cancer in the Netherlands.
de Jong EJM; Geurts SME; van der Geest LG; Besselink MG; Bouwense SAW; Buijsen J; Dejong CHC; Heij LR; Koerkamp BG; de Hingh IHJT; Hoge C; Kazemier G; van Laarhoven HWM; de Meijer VE; Mohammad NH; Strijker M; Timmermans KCAA; Valkenburg-van Iersel LBJ; Wilmink JW; Tjan-Heijnen VCG; de Vos-Geelen J;
Eur J Surg Oncol; 2021 Jul; 47(7):1742-1749. PubMed ID: 33712346
[TBL] [Abstract][Full Text] [Related]
31. Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry.
van Zeijl MCT; de Wreede LC; van den Eertwegh AJM; Wouters MWJM; Jochems A; Schouwenburg MG; Aarts MJB; van Akkooi ACJ; van den Berkmortel FWPJ; de Groot JWB; Hospers GAP; Kapiteijn E; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; van der Hoeven JJM; Haanen JBAG
Eur J Cancer; 2021 Feb; 144():242-251. PubMed ID: 33373869
[TBL] [Abstract][Full Text] [Related]
32. Incidence, Outcomes and Predictors of Primary Central Nervous System Melanoma: A SEER-Based Study.
Man W; Wang G
World Neurosurg; 2019 Sep; 129():e782-e790. PubMed ID: 31203063
[TBL] [Abstract][Full Text] [Related]
33. Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study.
Umeda Y; Yoshikawa S; Kiniwa Y; Maekawa T; Yamasaki O; Isei T; Matsushita S; Nomura M; Nakai Y; Fukushima S; Saito S; Takenouchi T; Tanaka R; Kato H; Otsuka A; Matsuya T; Baba N; Nagase K; Inozume T; Onuma T; Kuwatsuka Y; Fujimoto N; Kaneko T; Onishi M; Namikawa K; Yamazaki N; Nakamura Y
Eur J Cancer; 2021 Nov; 157():361-372. PubMed ID: 34563991
[TBL] [Abstract][Full Text] [Related]
34. Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.
Watson AS; Goutam S; Stukalin I; Ewanchuk BW; Sander M; Meyers DE; Pabani A; Cheung WY; Heng DYC; Cheng T; Monzon JG; Navani V
JAMA Netw Open; 2022 Dec; 5(12):e2245596. PubMed ID: 36480204
[TBL] [Abstract][Full Text] [Related]
35. Trends in the prognosis of metastatic melanoma in the era of targeted therapy and immunotherapy: A single-institution survey in Japan.
Matsui Y; Sasaki J; Takatsuka S; Takenouchi T
J Dermatol; 2021 Jan; 48(1):75-79. PubMed ID: 33063902
[TBL] [Abstract][Full Text] [Related]
36. Optimal resection margin for head and neck cutaneous melanoma.
Han AY; Dhanjani S; Pettijohn K; Patel PB; John MAS
Laryngoscope; 2019 Jun; 129(6):1386-1394. PubMed ID: 30408184
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
[TBL] [Abstract][Full Text] [Related]
38. Use of First-Line Immune Checkpoint Inhibitors and Association With Overall Survival Among Patients With Metastatic Melanoma in the Anti-PD-1 Era.
Lamba N; Ott PA; Iorgulescu JB
JAMA Netw Open; 2022 Aug; 5(8):e2225459. PubMed ID: 36006646
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
40. Nodal and distant metastases in sinonasal mucosal melanoma: A population-based analysis.
Low CM; Price DL; Moore EJ; Stokken JK; Van Abel KM; Janus JR; Choby G
Laryngoscope; 2020 Mar; 130(3):622-627. PubMed ID: 31077407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
